Application of Three-Dimensional Arterial Spin Labeling Technique in the Assessment of Cerebral Blood Perfusion in Patients with Middle Cerebral Artery Occlusion: Analysis of Clinical Implications and Prognostic Factors

Table 3

Comparison of baseline data between the two groups.

Factors	Good prognosis group ()	Poor prognosis group ()
Sex (male/female)	19/15	15/11	0.0197	0.8885
Age (years old)			2.7479	0.0080
Location of vascular occlusion			0.0247	0.8752
Left middle cerebral artery	15 (44.12)	12 (46.15)
Right middle cerebral artery	19 (55.88)	14 (53.85)
Collateral circulation			5.6681	0.0173
Good	21 (61.76)	8 (30.77)
Poor	13 (38.24)	18 (69.23)
Smoking history	14 (41.18)	10 (38.46)	0.0453	0.8315
Drinking history	19 (55.88)	16 (61.54)	0.1939	0.6597
History of hypertension	13 (38.24)	11 (42.31)	0.1018	0.7497
History of diabetes	14 (41.18)	9 (34.62)	0.2683	0.6045
History of coronary heart disease	16 (47.06)	12 (46.15)	0.0048	0.9445
NIHSS score (median (lower quartile, upper quartile))	3 (1.11)	8 (4.13)	3.0140	0.0038
Laboratory inspection index
Total cholesterol (mmol/L)			0.3104	0.7574
Triglyceride (mmol/L)			3.8447	0.0003
High-density lipoprotein (mmol/L)			1.1088	0.2721
Low-density lipoprotein (mmol/L)			1.0275	0.3084
Platelet count (×109/L)			0.3442	0.7319
White blood cell count (×109/L)			0.3605	0.7198
Albumin (g/L)			0.3399	0.7352
Hemoglobin (g/L)			1.7453	0.0862
Serum creatinine (mmol/L)			0.6801	0.4991
Uric acid (μmol/L)			1.1363	0.2605
Urea (mmol/L)			1.0659	0.2909
Homocysteine (mmol/L)			4.7489	<0.0001
Glutamic-pyruvic transaminase			0.3161	0.7531